|
|
|
|
|
Legal status
Patent lapsed (non-payment of fees)
| (51) | INT.CL. | A61P 7/00 | (2006.01) |
| (11) | Number of the document | 1957517 |
| (13) | Kind of document | T |
| (96) | European patent application number | 06789357.8 |
| Date of filing the European patent application | 2006-08-03 | |
| (97) | Date of publication of the European application | 2008-08-20 |
| (45) | Date of publication and mention of the grant of the patent | 2013-03-20 |
| (46) | Date of publication of the claims translation | 2013-08-26 |
| (86) | Number | PCT/US2006/030359 |
| Date | 2006-08-03 |
| (87) | Number | WO 2007/021572 |
| Date | 2007-02-22 |
| (30) | Number | Date | Country code |
| 200416 | 2005-08-09 | US |
| (72) |
MACDONALD, Brian, R., US
WEIS, Jeffery, Kenneth, US
YURKOW, Edward, John, US
|
| (73) |
Ortho-McNeil Pharmaceutical, Inc.,
US Route 202 South,, Raritan, NJ 08869,
US
|
| (74) |
Jurga PETNIŪNAITĖ,
AAA Law, A. Goštauto g. 40B, Verslo centras "Dvyniai", LT-03163 Vilnius,
LT
|
| (54) | Panaudojimas peptidų, kurie rišasi prie TPO receptoriaus |
| USE OF PEPTIDES THAT BIND TO TPO RECEPTOR |
| Payment date | Validity (years) | Amount | |
| 2022-07-26 | 17 | 347.00 EUR |
| Patent lapsed (non-payment of fees) | ||
| Invalidation date | 2023-08-03 |